StockTipsArenaBeta

BUY Piramal Pharma Limited — Motilal Oswal

BUYPiramal Pharma Limited

byMotilal OswalHorizon: NA (inferred 1 year)29 Apr 2026via Institutional / Brokerage Research

Entry₹160.15Inferred
Target₹190
Total upside +18.64% (call closed)
Stop lossNot given
Exit₹1907 May 2026, 12:05 pm
Target hit+18.64%0.00%upside left
Follow Motilal Oswal for new calls(61% target hit, 1112 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 7 active Long-term calls on PPLPHARMASee 177 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 6 Sept, 11:20 pm IST
1 supporting2 neutral0 opposing
Supports the BUY call (1)

1 other SEBI-registered advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·30 Apr · 1w ago

Neutral / worth noting (2)

Piramal Pharma Limited announced its financial results for the fourth quarter and full year of FY26 via a press release dated April 28, 2026.

NSE · Press Release·28 Apr · 1w ago

(opens in new tab)

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·28 Apr · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.